MedTrace Logo

Evaluation of the Not A Number Trafficking Prevention Program in Minnesota

NCT07503912 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 450

Last updated 2026-03-31

No results posted yet for this study

Summary

Although the exact scope of commercial sexual exploitation of children (CSEC) remains unknown, its significant negative physical and emotional consequences for children has been well-documented. The U.S. government recognized the need for improved CSEC prevention over two decades ago and recent legislation has been introduced to further increase funding for prevention programs. However, there is little evaluation research to guide communities on best practices, and questions remain about how to most effectively approach primary prevention for CSEC.

This study involves a randomized controlled trial (RCT) evaluation of the Not a Number (NAN)- a CSEC prevention program. NAN, developed by the non-profit organization Love 146, is delivered nationally with a unique train-the-trainer model in Minnesota to reach youth at heightened risk for CSEC victimization.

The RCT will be conducted at 32 implementation sites (15 youth enrolled as participants per site, N=480), with sites randomly assigned to an implementation or a wait-list control condition. We will examine a range of program outcomes, including a reduction in CSEC victimization (primary outcome), through a pre-test/post-test design (follow-up data collection at 6 weeks, 6 months, and 12 months).

Conditions

  • Commercial Sexual Exploitation

Interventions

BEHAVIORAL

Trafficking Prevention Education for Youth

The Trafficking Prevention Program involves 5 60 minute lesson modules

BEHAVIORAL

Mindfulness Training

30 minute mindfulness training program for youth designed by research staff

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
13 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-04-01
Primary Completion
2027-09-30
Completion
2027-09-30

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07503912 on ClinicalTrials.gov